Researchers have found that Sotyktu, which inhibits the protein TYK2, protects insulin-producing beta cells and, at the same ...

Low blood sugar contributes to eye damage and vision loss in diabetic retinopathy; an experimental drug may help treat the ...

Successfully treating type 2 diabetes may involve focusing on brain neurons, rather than simply concentrating on obesity or ...

Researchers discovered that inhibiting AgRP neurons in the hypothalamus of diabetic mice normalized blood sugar for months, ...

Recent technological advances are fueling the development of cutting-edge technologies that can monitor and control ...

A study co-led by Indiana University School of Medicine researchers presents a potential new strategy to prevent or slow the ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...

In type 1 diabetes, the body’s own immune system turns against the pancreas. Cells meant to protect you start destroying ...

A recent study reveals silencing specific brain neurons in the hypothalamus can normalize blood sugar in diabetic mice for ...

New study suggests a psoriasis drug could help slow or prevent Type 1 diabetes. Researchers target TYK2, an ...

Cerebral edema in diabetic ketoacidosis (DKA-CE ... Our objectives were to characterize an age-appropriate DKA mouse model and to determine which DKA therapies contribute to DKA-CE.